Signal Ventures

Accel-KKR is a leading mid-market software and technology investor, established in 2000 as a joint venture between leading venture investor Accel Partners and leading private equity firm KKR. Accel-KKR brings capital, expertise and a network of relationships to our portfolio companies, enabling them to grow faster and more profitably. Throughout the years, the firm has taken a collaborative approach to working with our management teams so that, together, we can help our companies reach their full potential. Accel-KKR focuses primarily on three types of transactions: buyouts of divisions, subsidiaries and business units from public companies; acquisitions and recapitalizations of closely-held private companies; and going-private transactions of small public companies.

Grok Ventures is the private investing vehicle of Mike Cannon-Brookes, co-founder of Atlassian and one of Australia's most successful technology entrepreneurs. Grok Ventures invests in fast-growing technology-enabled businesses with world-class management teams who are solving big problems. Grok particularly likes food and energy companies. We have private, patient, long-term capital, with the flexibility to participate from early-stage or seed financing through to late stage funding rounds (although we prefer to be involved earlier).

Pacific Equity Partners (PEP) is the largest private equity firm in Australia and New Zealand. PEP invests through buyouts and growth capital into a wide range of industries including industrial services, energy, consumer products, entertainment and financial services. PEP prefers to invest in companies with major operations in Australia or New Zealand and with Enterprise Values between A$200m and A$1bn. It typically invests for between three and six years. PEP was founded in 1998 by senior Australian partners of the leading strategy consulting firm Bain & Co.

Uniseed is a venture fund operating at the Universities of Melbourne, Queensland, Sydney & New South Wales, and the CSIRO, with investment capital provided by the five partner research organisations. Since October 2000, our mandate has been to facilitate the commercialisation of research partner-generated intellectual property by targeted investment in highly promising technologies. Uniseed's partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia.

OneVentures is one of Australia's leading venture capital firms, with over $900 million in funds under management. We work with companies to take them to that all important next stage, by actively shaping their future. We apply our years of experience, expertise, operational and executional excellence to accelerate their growth and launch them into global markets. OneVentures invests in biotechnology, life sciences and other technology applications. We look for truly innovative products tackling multi-billion-dollar world problems, from needle-free vaccinations to next-generation learning technologies to virtual communications.

Reinventure exists at the third horizon of growth, focused on creating options in future businesses through venture investment and a strategic relationship with our largest limited partner, Westpac Banking Corporation. With $100m to invest in FinTech and adjacent areas, we are uncovering, investing in and nurturing scalable early businesses that will be the future of the industry.